Position in ICLR
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$4,160,875
-$2,574,113 QoQ
Shares Held
23,953
-60.6% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#139
of 422 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ICLR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026DNB Asset Management AS holds $185,775,748 across 19 Diagnostics & Research names. ICLR ranks #12 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
117,013 | $58,665,637 | |
| 2 | DHR |
Danaher Corp /De/
|
200,399 | $38,172,001 | |
| 3 | IQV |
Iqvia Holdings Inc.
|
97,078 | $18,757,411 | |
| 4 | LH |
Labcorp Holdings Inc.
|
37,799 | $10,583,720 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
19,446 | $10,237,152 | |
| 6 | A |
Agilent Technologies, Inc.
|
63,445 | $8,427,399 | |
| 7 | WAT |
Waters Corp /De/
|
21,718 | $8,145,118 | |
| 8 | NTRA |
Natera, Inc.
|
28,470 | $7,728,181 |
All Filings in ICLR
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,160,875 | 23,953 | Shares | Other | 2026-08-11 | |
| 2026-03-31 | $6,734,988 | 60,862 | Shares | Other | 2026-05-14 | |
| 2025-12-31 | $5,938,367 | 32,589 | Shares | Other | 2026-02-05 | |
| 2025-09-30 | $4,339,125 | 24,795 | Shares | Other | 2025-11-12 | |
| 2025-06-30 | $4,486,987 | 30,849 | Shares | Other | 2025-08-12 | |
| 2025-03-31 | $6,336,037 | 36,208 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $8,018,890 | 38,238 | Shares | Other | 2025-02-12 | |
| 2024-09-30 | $6,252,440 | 21,762 | Shares | Other | 2024-11-12 | |
| No filing history on record for this holder in this stock. | ||||||